Sobi Returns To Deal-Making With ADC Lymphoma Licensing Pact

Pays $55m Upfront For Rights To Zynlonta

Guido Oelkers
Sobi CEO Guido Oelkers • Source: Archive
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Rare Diseases

More from Scrip